Private equity firm

July 22, 2018

Represented a private equity firm focused on market leaders in healthcare in its acquisition of the nation’s leading provider of infusion products, supplies, biomedical services and technology solutions to the home infusion therapy market. We advised on the healthcare regulatory aspects of the transaction.
Back to top